Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medicare Rx Disease Management Pilot Project Estimated To Cost $300 Mil.

Executive Summary

A disease management program pilot project included in the House Medicare drug benefit bill (HR 4680) may have difficulty attracting private sector contractors, a Congressional Budget Office analysis of the bill indicates.
Advertisement

Related Content

House State-Based Senior Rx Plan Includes Funds For Pharmacy Services
House State-Based Senior Rx Plan Includes Funds For Pharmacy Services
Medicare Clinical Trial Policy May Improve Outcomes Data - HHS Panelist
Medicare Clinical Trial Policy May Improve Outcomes Data - HHS Panelist
AARP Engages In Medicare Rx Debate; Focus Shifts To Senate
AARP Engages In Medicare Rx Debate; Focus Shifts To Senate
Advertisement
UsernamePublicRestriction

Register

PS036308

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel